TNF Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNFA and other ETFs, options, and stocks.About TNFA
TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms.
CEOChristopher C. Chapman, Jr., MD
CEOChristopher C. Chapman, Jr., MD
Employees2
Employees2
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1989
Founded1989
Employees2
Employees2
TNFA Key Statistics
Market cap11.04M
Market cap11.04M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume63.06M
Average volume63.06M
High today$0.0715
High today$0.0715
Low today$0.0609
Low today$0.0609
Open price$0.07
Open price$0.07
Volume59.13M
Volume59.13M
52 Week high$1.95
52 Week high$1.95
52 Week low$0.0609
52 Week low$0.0609
People also own
Based on the portfolios of people who own TNFA. This list is generated using Robinhood data, and it’s not a recommendation.